Question 1

What is the catalog number for Anti-H3 (A/Brisbane/299/2011) (H3N2)?

Accepted Answer

The catalog number for Anti-H3 (A/Brisbane/299/2011) (H3N2) is IT-003-00425M2.

Question 2

What sizes are available for Anti-H3 (A/Brisbane/299/2011) (H3N2)?

Accepted Answer

Anti-H3 (A/Brisbane/299/2011) (H3N2) is available in the following size(s): 0.1 mg, 0.5 mg.

Question 3

How many pack sizes does Anti-H3 (A/Brisbane/299/2011) (H3N2) come in?

Accepted Answer

Anti-H3 (A/Brisbane/299/2011) (H3N2) is available in 2 different pack sizes.

Question 4

Is Anti-H3 (A/Brisbane/299/2011) (H3N2) in stock?

Accepted Answer

Anti-H3 (A/Brisbane/299/2011) (H3N2) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is the recommended dilution for this antibody?

Accepted Answer

A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.

Question 6

What is the recommended storage temperature after reconstitution?

Accepted Answer

Post-reconstitution storage guidance is listed on the datasheet, typically requiring aliquoting and storage at -20°C or -80°C to preserve activity.

Question 7

Can this product be used in multiplex assays?

Accepted Answer

Multiplex compatibility depends on the specific product and detection panel. Contact our technical support team with details of your multiplex system for guidance before ordering.

Anti-H3 (A/Brisbane/299/2011) (H3N2)

Product Specifications

Type

Applications

Available Sizes

Frequently Asked Questions

Explore Other Products

CD44v6 (Marker of Tumor Metastasis) (CD44V6/2496), CF405S conjugate, 0.1mg/mL

CD68 (C68/684), CF647 conjugate, 0.1mg/mL

CD163 (Monocyte & Macrophage Marker) (M130/2164), CF647 conjugate, 0.1mg/mL

Cytokeratin 18 (KRT18/835), CF594 conjugate, 0.1mg/mL

NSE gamma (Neuron Specific Enolase, gamma) (Neuroendocrine Marker) (ENO2/1462), CF405S conjugate, 0.1mg/mL

CD44v9 (Marker of Tumor Metastasis) (CD44v9/2344R), CF568 conjugate, 0.1mg/mL